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Serous cystadenoma of the pancreas are rare tumors and have little or no malignant potential.
We report our experience in the management of eight casses of these tumors in the last 22 years. All the
patients were women with a mean age of 59 years. All the cysts caused symptoms. Ultrasound and CT-
scan were useful in the diagnosis of the pancreatic cystic tumor out not in determining the nature of these
lesions clear. FNA-biopsy was performed in 6 cases but in only one c se was the diagnosis confirmed. All
tumors were resected. Four radical pancreatoduodenectomies, two distal pancreatectomies and two
cystectomies were performed. Mean followup was 83.5 months. All patients are alive and with no signs of
recurrence. Complications include an external pancreatic fistula, an acute cholangitis and a case of
delayed gastric emptying. In all cases the histological diagnosis was serous cystadenoma of the pancreas.
We conclude that resection of these tumors is mandatory although they are supposed to be benign, in
order to avoid complications and because malignant transformations has been related to nonresective
treatment.
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Serous cystadenoma of the pancreas are rare tumors
(9 to 13% ofpancreatic cystic lesions) and have little or
no malignant potential. 1’2’3.
With the improvement in imaging technology, sev-
eral cystic lesions ofthe pancreas have been recognized
(Table 1).2 and the differential diagnosis is sometimes
difficult.
We report our experience in the management of 8
patients with this kind of tumor in the last 22 years.
Clinical presentation, diagnostic studies, surgical
treatment and follow up is described with a brief re-
view of the literature.
Table 1 Classification of Pancreatic Cystic Tumors (Warshaw
et al.)2.
Pancreatic Cystic Tumors
-Serous cystadenoma (glycogen rich adenoma, microcystic
adenoma)
-Mucinous cystadenoma (mucinous cystic
neoplasm, macrocystic adenoma)
-Papillary cystic tumor (papillary and
cystic neoplasm, solid and papillary neoplasm)
-Cystic islet cell tumor
-Pseudocyst
MATERIALS AND METHODS
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The clinical records ofeight patients with the diagnosis
of serous cystadenoma of the pancreas surgically
resected by our group in the last 22 years were
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reviewed. All pathology specimens were re-assesed
and the diagnosis confirmed. The current situation of
each patient was established by means of a full physi-
cal examination.
endoscopically, finally, one patient developed delayed
gastric emptying wich resolved spontaneously.
In all cases the histological findings were serous
cystadenoma of the pancreas. Immunohistochemical
findings are summarized in Table 3.
RESULTS
All patients were women, with a mean age of 59
years (range 38-76 ys). All cysts caused symptoms,
including epigastic pain, abdominal discomfort, nau-
sea, weight loss and weakness (Table 2).
Ultrasound (US) was performed in all cases and
CT-scan in the last six. In one case, before the advent
of CT scanning, the tumor’s origin was not clarified
Table 2 Clinical Manifestations of 8 patients with serous
cystadenoma of the pancreas.
Clinical Manifestations
Epigastric pain or discomfort 8 cases
Palpable abdominal mass 4 cases
Nausea-Vomiting 2 cases
Weight loss 2 cases
Weakness case
and in all the other patients these studies revealed a
pancreatic cystic mass. In only one case serous
cystadenoma was stated to be the most likely diagnosis
and it was confirmed by fine needle aspiration (FNA)
biopsy. FNA biopsy was performed under US-CT
guidance in four cases and during the surgical proce-
dure in two. No malignant cells were found, and in the
case described above the diagnosis was made.
Four tumors were located in the head and the other
four in the body ofthe pancreas. Themean size was 8.6
cm (range 3-20 cm) and there was no relationship
between size and anatomical location.
All tumors were resected. Four radical pancreato-.
duodenectomies, two distal pancreatectomies and two
cystectomies were performed.
Mean follow up was 83.5 months (range 12-264
months). All patients are alive and with no signs of
recurence. One patient who underwent a radical
pancreatoduodenectomy, developed an external pan-
creatic fistula, draining approximately 5 cc per 24
hours till it spontaneously closed 38 months after the
resection. Another developed an episode of acute
cholangitis secondary to a stone in the common bile
duct and stenosis of the bilioenteric anastomosis 30
months after surgery. She was successfully treated
DISCUSSION
Adloff in 1863, Fitz in 1900 and Malcolm in 1906
reported the earliest cases ofpancreatic cystadenoma
4
but it was not until 1978 that Compagno and Ortel
fully described the differences between serous and
mucinous cystic tumors of the pancreas.
Serous cystadenomas are considered to be benign as
opposed to the mucinous cystadenomas which are
malignant or premalignant tumors. During the past
few years multiple classifications of these tumors have
appeared with great similarities in the nomenclature.
(Table 1)2
Serous cystadenomas occur more frequently in fe-
males in the sixth and seventh decades, but ranging
from 13 to 83 years of age. 1’2’5’6 They are usually quite
large, averaging 10 cm in diameter1’2. Compagno and
Ortel described them as made up of many tiny cysts
lined by small cuboid cells containing glycogen but
little or no mucin, forming a honeycomb pattern with
no evidence of atypia. 2’7 Serous cystadenoma can oc-
cur in any segment ofthe pancreas and have also been
described in ectopic pancreatic tissue.6’8’9 In our series,
the lesions developed in youngerwomen and only two
ofthem were larger than 10 cm.
The pathogenesis is unknown. 1’8’1 They are some-
times associated with extrapancreatic symptoms such
as sterility, thymic dysfunciton, hypertension, diabetes
mellitus, gallstones and Zollinger Ellison syndrome.
No relationship has been established between the
tumor and any ofthe above clinical conditions neither
in our series nor in the literature.8’11’1
Pain is the mostcommon symptom, being present in
about 80% of cases, and is usually due to compression
of contiguous structures. Other manifestations of the
disease include weight loss, nausea and vomiting.
Table 3 Immunohistochemical Findings in 8 cases of serous
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The rest of the patients are usually asymptomatic
and in many cases the tumor is discovered during
a routine clinical examination.2’13 Occasionally they
are found during work-up for other clinical prob-
lems.14
For a patient with a suspected cystadenoma of
the pancreas, is it necessary to perform a surgical
procedure for what is ultimately a benign condition?
To us the answer is clear for although a spectrum of
findings associated with serous cystadenoma have
been described and Johnson et al. were able to cor-
rectly differentiate about 95% of serous cystadenoma
from other cystic lesions of the pancreas
15 it is very
difficult to differentiate a serous from a mucinous
cystadenoma based only in the US-CT combination.
Magnetic resonance imaging (MRI) is more expensive
and has not demonstrated its superiority except for
patients who cannot tolerate iodine-containing con-
trast material.
16
FNA biopsy has been suggested as useful for con-
firming malignant tumors in unclear cases. 17 However
it has several potential pitfalls, including sampling
error and complications such as malignant cells spill-
ing and seeding)’18 Analysis of cyst contents may be
useful. Serous cystadenomas have no mucin and posi-
tive immunostaining for the cytokeratins AE1 and
AE3 or positive PAS reaction.
19
In our experience, in only one case the US-CT
findings suggested a serous cystadenoma and al-
though we performed FNA biopsy in six cases (4
percutaneous with US-CT guidance and 2
intraoperatively ) only in this one case was the diagno-
sis confirmed.
Considering our experience and the fact that 2 cases
of serous cystadenocarcinoma have been reported re-
cently2’21 We conclude that a surgical procedure is
necessary in order to confirm the diagnosis.
Another issue is which is the best surgical procedure
for the resection of these tumors. The safety of the
resection becomes an important consideration and is
based primarily on the location of the tumor and the
experience ofthe surgeon. Lesions in the body and tail
of the pancreas are easily amenable to distal pan-
createctomy while tumors of the head and of the
uncinate process would require aWhipple procedure.
We followed this rule in six cases but enucleation was
performed in two cases and no signs of relapse were
found. We believe that resection, must be performed if
possible, because complications such as hemorrhage,
chronic pancreatitis, recurrent acute pancreatitis, ob-
structive symptoms and even malignant transforma-
20 23 tion have been related to nonresective treatment.
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